Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

786 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predictors of short-term clinical response to cardiac resynchronization therapy.
Linde C, Abraham WT, Gold MR, Daubert JC, Tang ASL, Young JB, Sherfesee L, Hudnall JH, Fagan DH, Cleland JG. Linde C, et al. Among authors: young jb. Eur J Heart Fail. 2017 Aug;19(8):1056-1063. doi: 10.1002/ejhf.795. Epub 2017 Mar 14. Eur J Heart Fail. 2017. PMID: 28295869 Free article. Review.
Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.
Abraham WT, Young JB, León AR, Adler S, Bank AJ, Hall SA, Lieberman R, Liem LB, O'Connell JB, Schroeder JS, Wheelan KR; Multicenter InSync ICD II Study Group. Abraham WT, et al. Among authors: young jb. Circulation. 2004 Nov 2;110(18):2864-8. doi: 10.1161/01.CIR.0000146336.92331.D1. Epub 2004 Oct 25. Circulation. 2004. PMID: 15505095 Clinical Trial.
Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials.
Pires LA, Abraham WT, Young JB, Johnson KM; MIRACLE and MIRACLE-ICD Investigators. Pires LA, et al. Among authors: young jb. Am Heart J. 2006 Apr;151(4):837-43. doi: 10.1016/j.ahj.2005.06.024. Am Heart J. 2006. PMID: 16569543
Precision Medicine for Cardiac Resynchronization: Predicting Quality of Life Benefits for Individual Patients-An Analysis From 5 Clinical Trials.
Nassif ME, Tang Y, Cleland JG, Abraham WT, Linde C, Gold MR, Young JB, Daubert JC, Sherfesee L, Schaber D, Tang ASL, Jones PG, Arnold SV, Spertus JA. Nassif ME, et al. Among authors: young jb. Circ Heart Fail. 2017 Oct;10(10):e004111. doi: 10.1161/CIRCHEARTFAILURE.117.004111. Circ Heart Fail. 2017. PMID: 29038172 Free PMC article.
Beta-blocker use and outcomes among hospitalized heart failure patients.
Butler J, Young JB, Abraham WT, Bourge RC, Adams KF Jr, Clare R, O'Connor C; ESCAPE Investigators. Butler J, et al. Among authors: young jb. J Am Coll Cardiol. 2006 Jun 20;47(12):2462-9. doi: 10.1016/j.jacc.2006.03.030. J Am Coll Cardiol. 2006. PMID: 16781374 Free article.
The importance of early evaluation after cardiac resynchronization therapy to redefine response: Pooled individual patient analysis from 5 prospective studies.
Chung ES, Gold MR, Abraham WT, Young JB, Linde C, Anderson C, Lu X, Ikuemonisan JO, Fagan DH, Tsintzos SI, Rickard J. Chung ES, et al. Among authors: young jb. Heart Rhythm. 2022 Apr;19(4):595-603. doi: 10.1016/j.hrthm.2021.11.030. Epub 2021 Nov 26. Heart Rhythm. 2022. PMID: 34843964 Free article.
786 results